entertainment -WSS

entertainment

author：Wikipedia 2025-09-03 11:59:39 - browse：21825

Daphne Koller -- biotech coverage from STAT — Daphne Koller, early biotech AI entrant Insitro's founder, CEO and board member. Courtesy Jerrick Mitra/Insitro

New artificial intelligence technologies made headlines last year for their ability to do everything from generating fake musical duets to understanding how proteins fold. But in biotech, one of the most well-funded AI players has been quiet.

Insitro, a South San Francisco firm, was founded in 2018 by Daphne Koller, who had previously been a Stanford professor, a 2004 MacArthur “genius” grant recipient, and the co-founder and co-CEO of the online course company Coursera. It raised more than $643 million in venture capital, according to PitchBook, from investors including T. Rowe Price, ARCH Venture Partners, and Casdin Capital. The company now has more than 260 employees spread out over 107,000 square feet of laboratory and office space.

But what exactly is Koller building?

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： Bispecific antibodies are next new thing in cancer immunotherapy

entertainment

WSS

Reanimated hearts work just as well for transplants, study finds

Military medical care influenced by rank and race, new study finds

Novo pauses ads for weight loss drug Wegovy amid demand

Living organ donors deserve priority status for transplants

Inside the rise of 'mukbang' eating videos

Arc Institute generative AI designs new CRISPR systems

focus

entertainment

hotspot

Medical records are filled with copy

How a billionaire couple greased the skids for Pelosi’s drug pricing bill

Novavax promises a turnaround & Lilly roils the obesity market

Bird flu: Don't repeat Covid's 'health versus the economy' framing

Jerome Adams on the need for new antivirals for Covid

Criminal prosecution for violating HIPAA: an emerging threat

Heart attack and stroke risk calculators need revising

Novo: Oral version of Ozempic leads to 15% weight loss

Dobbs anniversary: the lost opportunity of abortion as health care

A public health expert passes on football's full body collisions for youths

knowledge

Arc Institute generative AI designs new CRISPR systems

NVIDIA and Google execs on the future of AI and drug discovery

Solving academic medical centers' existential crisis

When prostate cancer spreads, where it goes matters

Readout Newsletter: Nvidia, Biogen, Ionis, AstraZeneca, ChatGPT

Readout LOUD podcast: Live from STAT Breakthrough Summit West

explore

entertainment

leisure time

hotspot